Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.

https://doi.org/10.1182/hematology.2019000006

Published: 2019

Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.

https://doi.org/10.1182/hematology.2019001321

Published: 2019

Journal Articles

The MDS genomics-prognosis symbiosis

Aziz Nazha

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 270–276.

https://doi.org/10.1182/asheducation-2018.1.270

Published: 2018

Journal Articles

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Monika Brüggemann, Michaela Kotrova

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 13–21.

https://doi.org/10.1182/asheducation-2017.1.13

Published: 2017

Journal Articles

Treatment of older patients with acute lymphoblastic leukemia

Nicola Gökbuget

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 573–579.

https://doi.org/10.1182/asheducation-2016.1.573

Published: 2016

Journal Articles

Prognostication of chronic lymphocytic leukemia in the era of new agents

Barbara Eichhorst, Michael Hallek

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 149–155.

https://doi.org/10.1182/asheducation-2016.1.149

Published: 2016

Journal Articles

Prognostic factors in follicular lymphoma: new tools to personalize risk

Carla Casulo

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 269–276.

https://doi.org/10.1182/asheducation-2016.1.269

Published: 2016

Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.

https://doi.org/10.1182/asheducation-2016.1.356

Published: 2016

Journal Articles

Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease

Julien Haroche, Oussama Abla

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 571–578.

https://doi.org/10.1182/asheducation.V2015.1.571.3916289

Published: 2015

Journal Articles

Evolving diagnostic criteria for multiple myeloma

S. Vincent Rajkumar

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 272–278.

https://doi.org/10.1182/asheducation-2015.1.272

Published: 2015

Journal Articles

Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease

Eliane Gluckman

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 370–376.

https://doi.org/10.1182/asheducation-2013.1.370

Published: 2013

Journal Articles

Treatment of acute myeloid leukemia: are we making progress?

Alan K. Burnett

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 1–6.

https://doi.org/10.1182/asheducation.V2012.1.1.3797038

Published: 2012

Journal Articles

Minimal residual disease in acute myeloid leukemia: coming of age

Elisabeth Paietta

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 35–42.

https://doi.org/10.1182/asheducation.V2012.1.35.3797926

Published: 2012

Journal Articles

Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma

Laurie H. Sehn

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 402–409.

https://doi.org/10.1182/asheducation.V2012.1.402.3798516

Published: 2012

Journal Articles

Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?

Elizabeth A. Raetz, Teena Bhatla

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 129–136.

https://doi.org/10.1182/asheducation.V2012.1.129.3800156

Published: 2012

Journal Articles

Minimal Residual Disease in Acute Lymphoblastic Leukemia

Dario Campana

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 7–12.

https://doi.org/10.1182/asheducation-2010.1.7

Published: 2010

Journal Articles

Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Wendy Stock

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 21–29.

https://doi.org/10.1182/asheducation-2010.1.21

Published: 2010

Journal Articles

Upcoming Diagnostic and Therapeutic Developments in Classical Hodgkin's Lymphoma

Kristie A. Blum

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 93–100.

https://doi.org/10.1182/asheducation-2010.1.93

Published: 2010

Journal Articles

Ultra High-Risk Myeloma

Hervé Avet-Loiseau

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 489–493.

https://doi.org/10.1182/asheducation-2010.1.489

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome

Corey Cutler

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 325–329.

https://doi.org/10.1182/asheducation-2010.1.325

Published: 2010

NARROW

Minimal residual disease and stem cell transplantation outcomes

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

The MDS genomics-prognosis symbiosis

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Treatment of older patients with acute lymphoblastic leukemia

Prognostication of chronic lymphocytic leukemia in the era of new agents

Prognostic factors in follicular lymphoma: new tools to personalize risk

MRD in AML: does it already guide therapy decision-making?

Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease

Evolving diagnostic criteria for multiple myeloma

Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease

Treatment of acute myeloid leukemia: are we making progress?

Minimal residual disease in acute myeloid leukemia: coming of age

Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma

Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?

Minimal Residual Disease in Acute Lymphoblastic Leukemia

Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Upcoming Diagnostic and Therapeutic Developments in Classical Hodgkin's Lymphoma

Ultra High-Risk Myeloma

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only